Home
About
Publications Trends
Recent Publications
Expert Search
Archive
protein translation
How is Protein Translation Dysregulated in Cancer?
In cancer, several mechanisms can lead to the dysregulation of protein translation. These include:
Mutations
in genes encoding translation factors
Overexpression of
oncogenic pathways
like the mTOR pathway
Altered expression of
microRNAs
that regulate translation
Changes in the availability of
ribosomal proteins
These alterations can result in the selective translation of oncogenes and other proteins that promote cancer progression.
Frequently asked queries:
How Does Protein Translation Work?
How is Protein Translation Dysregulated in Cancer?
Which Cancer Types are Most Affected by Translation Dysregulation?
Can Protein Translation be Targeted for Cancer Therapy?
What are the Challenges in Targeting Protein Translation?
Who Provides Psychosocial Support?
How does alcohol contribute to cancer development?
What are the Strategies to Overcome Treatment Resistance?
What is DNA Damage?
What Training Should Yoga Instructors Have to Work with Cancer Patients?
Why is AFP Important in Hepatocellular Carcinoma?
What are Algorithms in Cancer Research?
What Are the Risks of Cardiovascular Disease for Cancer Patients?
What Is the Role of Robotic Surgery in Cancer Treatment?
How Can Lung Cancer be Prevented?
What Role Do Soft Skills Play in Cancer Care?
How Do Interoperable Systems Benefit Patients?
What are the Common Signs and Symptoms?
Why is Bioavailability Important in Cancer Treatment?
What are Some Successful Examples of Data Sharing Initiatives?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Diagnostics
Cancer Genomics
Chemotherapy
Essential Thrombocythemia
hepatocellular carcinoma
Lung Cancer
Molecular Biomarkers
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
CALR Mutation
cancer
cancer diagnosis
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
cell-free RNA
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
circulating tumor cells
circulating tumor DNA
Clonal Expansion
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Cytoreductive Therapyexpansion
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
early detection
epirubicin-cyclophosphamide
Essential Thrombocythemia
exosomes
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
JAK2 Mutation
Keratinocyte
Lipid-based nanoparticles
Liquid Biopsies
Liquid biopsy
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
Megakaryocytes
metastasis
methyltransferase
minimal residual disease
Molecular Biomarkers
MPL Mutation
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Myeloproliferative Neoplasm
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
non-invasive diagnostics
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Personalized Treatment
Photobiomodulation therapy
Platelets
Polymeric nanoparticles
portal vein tumor thrombus
precision medicine
Precision Oncology
Predictive Biomarkers
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Resistance Mechanisms
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted Therapies
Targeted therapy
Thrombosis
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Tumor-Agnostic Treatments
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe